Search for Clinical Trial Results

Hyperparathyroidism - 63 Studies Found
Status | Study |
Completed |
Study Name: Cinacalcet to Treat Familial Primary Hyperparathyroidism Condition:
Date: 2006-05-11 Interventions:
|
Completed |
Study Name: A Prospective Cohort Study to Describe the Evolution of Persistent Hyperparathyroidism in Kidney Transplant Recipients Condition: Hyperparathyroidism Date: 2010-07-14 |
Completed |
Study Name: Primary Hyperparathyroidism: Non-classical Manifestations Condition: Primary Hyperparathyroidism Date: 2007-02-06 |
Completed |
Study Name: Energy Specific Far Infrared Radiation Treatment for Hyperparathyroidism Condition: Hyperparathyroidism Date: 2007-12-12 Interventions: Radiation: Far Infrared Radiation Far Infrared Radiation (5μm to 20μm wavelength) for 30 to 40 |
Completed |
Study Name: Association Between Serum Periostin Levels and Cortical Porosity in Patients With Secondary Hyperparathyroidism Condition: Hyperparathyroidism Date: 2015-08-13 Interventions:
|
Recruiting |
Study Name: Primary Hyperparathyroidism: Short-term Calcimimetics Treatment - Relevance for Parathyroid Surgery Decisions? Condition: Primary Hyperparathyroidism Date: 2014-08-17 Interventions:
|
Completed |
Study Name: Denosumab in Primary Hyperparathyroidism Condition: Primary Hyperparathyroidism Date: 2012-03-16 Interventions:
|
Completed |
Study Name: A Multicenter, Open-label Extension Study to Assess the Long-term Safety and Efficacy of an Oral Calcimimetic Agent AMG 073 (Cinacalcet) in Primary Hyperparathyroidism Condition: Hyperparathyroidism, Primary Date: 2009-06-04 Interventions: Drug: cinacalcet Subjects began open-label treatment with 30 mg cinacalcet twice daily (BID) at the star |
Withdrawn |
Study Name: The Effects of Alendronate After Cure of Primary Hyperparathyroidism Condition: Hyperparathyroidism Date: 2006-08-01 Interventions: Drug: Alendronate 70mg weekly 70mg weekly Other Name |
Completed |
Study Name: A Study to Assess the Efficacy and Safety of Twice-Daily Dose Regimens of an Oral Calcimimetic Agent AMG 073 (Cinacalcet) in Primary Hyperparathyroidism (PHPT) Condition: Hyperparathyroidism, Primary Date: 2009-06-04 Interventions:
|